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Abstract
Introduction: Klebsiella is a clinically important pathogen causing a variety of antimicrobial resistant infections in
both community and nosocomial settings, particularly pneumonia, urinary tract infection, and sepsis. Bacteriophage
(phage) therapy is being considered a primary option for the treatment of drug-resistant infections of these types.
Methods: We report the successful isolation and characterization of 30 novel, genetically diverse Klebsiella phages.
Results: The isolated phages span six different phage families and nine genera, representing both lysogenic and
lytic lifestyles. Individual Klebsiella phage isolates infected up to 11 of the 18 Klebsiella capsule types tested,
and all 18 capsule-types were infected by at least one of the phages.
Conclusions: Of the Klebsiella-infecting phages presented in this study, the lytic phages are most suitable for
phage therapy, based on their broad host range, high virulence, short lysis period and given that they encode no
known toxin or antimicrobial resistance genes. Phage isolates belonging to the Sugarlandvirus and Slopekvirus
genera were deemed most suitable for phage therapy based on our characterization. Importantly, when applied
alone, none of the characterized phages were able to suppress the growth of Klebsiella for more than 12 h, likely
due to the inherent ease of Klebsiella to generate spontaneous phage-resistant mutants. This indicates that for
successful phage therapy, a cocktail of multiple phages would be necessary to treat Klebsiella infections.
Keywords: Klebsiella, bacteriophage, phage, phage therapy, antimicrobial resistance, antibiotics, nosocomial
infection, characterization, virulence
Background
The Klebsiella genus causes pneumonia, urinary tractinfection, and sepsis, particularly in vulnerable popula-
tions, often causing secondary infections in ventilated or ca-
theterized patients, in both the community and nosocomial
settings.1–4 In addition, the subclinical carriage of Klebsiella is
linked to cardiovascular5,6 and inflammatory bowel disease.7
Klebsiella pneumoniae is the most problematic species giving
rise to hypervirulent clones with extended virulence factors.8–11
Antimicrobial resistance (AMR) represents a threat to
global health and security, fueled by our intensive use of
antibiotics in medicine and agriculture. Klebsiella readily
gains and transfers AMR genes, particularly in health care
settings, making it a World Health Organization priority
pathogen.12,13 The prevalence of multi-drug resistant (MDR)
Klebsiella has increased exponentially to most available an-
timicrobial drugs, and cases of pan-resistant Klebsiella are
now common around the world.14–17 MDR Klebsiella infec-
tions pose an increased risk of mortality,18,19 are difficult to
treat20,21 and outbreaks are economically costly.19 Bacter-
iophages (phages)22 offer one potential alternative treatment.
Phage therapy is a potential weapon against MDR bacterial
infections.23,24 Phage therapy depends on preparedness,
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particularly in having a real or virtual ‘‘biobank’’ of charac-
terized phages against common AMR bacteria. Phage char-
acterization is essential to provide effective, timely treatment
and mitigate side effects.25
In this article, we use genomic and imaging technologies to
characterize novel phages isolated against Klebsiella spp.
Phages were isolated from rivers, ponds, estuaries, canals,
slurry, and sewage. Their characterization focused on their
infection cycle, host range, and gene content. We present
phages with siphovirus, myovirus, podovirus, and inovirus
morphologies, spanning six phage families and nine genera,
of which the majority have lytic lifestyles. A number of these
phages have potential use in phage therapy.
Materials and Methods
Bacterial strains and culture conditions
The Klebsiella strains used in this work are listed in
Table 1. All culturing in liquid medium was performed with
shaking (150 rpm) at 37C. All culturing was carried out in
Lysogeny broth (LB), with the addition of 5 mM CaCl2 and
MgCl2. The Klebsiella were originally isolated from clinical
and environmental samples (Table 1). They represented six
species: K. pneumoniae, Klebsiella oxytoca, Klebsiella qua-
sipneumoniae, Klebsiella variicola, Klebsiella michagenesis,
and Klebsiella aerogenes.
No ethical approval was required for this work.
Klebsiella capsule typing
Kaptive Web was used to determine the capsule (K) and
LPS antigen (O) locus types of the 24 Klebsiella strains.
Phage isolation
Phages were isolated from water samples from various
sources, listed in Table 2. Water samples were filtered through
0.2 lm pore-size syringe filters to remove debris and bacteria.
Phages were then isolated by enrichment: 2.5 mL of filtered
water was added to 2.5 mL nutrient broth, containing 5 mM
CaCl2 and 5 mM MgCl2, and inoculated with 50 lL of
overnight-grown Klebsiella. This enrichment culture was then
incubated overnight at 37C and centrifuged, and the superna-
tant was filtered through a 0.2lm pore-size filter to remove
cells. This filtrate was serially diluted to 10-11 in LB and used in
an overlay agar plaque assay.
Briefly, 50 lL of each serial dilution was mixed with 0.5 mL
of a single Klebsiella strain in the logarithmic growth phase
(approximately OD600nm 0.2) and incubated at room temper-
ature for 5 min. To each serial dilution/cell mix, 2.5 mL of
cooled, molten LB agar (0.4% weight/volume) was added and
mixed by swirling. The molten agar mix was poured onto 1%
LB agar plates. Overlay agar plates were allowed to set, then
inverted, and incubated overnight at 37C. From the plaque
assay plates, single plaques were picked, mixed with 50 lL of
LB, and filtered through a 0.22 lm pore-size spin filter (Costar
Spin-X; Corning, United Kingdom). This filtrate underwent
two further rounds of plaque assay to ensure that clonal phages
were isolated. Phages were named by using the ICTV binomial
system of viral nomenclature.26
DNA extraction
DNA was extracted by using the phenol–chloroform
method.27 Briefly, phage lysates were concentrated by using






host? Origin Isolation source
Klebsiella aerogenes 30053 — U DSMZ Culture Collection Sputum
Klebsiella michiganensis 25444 O1v1 · DSMZ Culture Collection Toothbrush holder
Klebsiella oxytoca 170748 O1v1 · Clinical Isolate Catheter specimen urine
5175 KL29 · DSMZ Culture Collection Pharyngeal tonsil
25736 KL74 U DSMZ Culture Collection Case of pneumonia
170821 OL104 U Clinical Isolate Urine
171266 OL104 · Clinical Isolate Urostomy urine
Klebsiella pneumoniae 170958 KL28 U Clinical Isolate Urine
171304 KL144 · Clinical Isolate Catheter specimen urine
13440 KL38 U NCTC Culture Collection Clinical
13442 KL110 · NCTC Culture Collection Hospital, Italy
30104 KL3 U DSMZ Culture Collection Human blood
13465 KL57 · NCTC Culture Collection Clinical
170820 KL158 · Clinical Isolate Urine
16358 KL4 · DSMZ Culture Collection Human, nose
170723 KL2 U Clinical Isolate Urine
171167 KL2 · Clinical Isolate Urine
13443 KL2 · NCTC Culture Collection Clinical
13882 KL64 · ATCC Culture Collection Water
13439 KL14 U NCTC Culture Collection Outbreak strain
Klebsiella variicola W12 KL14 · Environmental Isolate Soil
15968 KL16 U DSMZ Culture Collection Banana root
Klebsiella
quasipneumoniae
28211 KL35 U DSMZ Culture Collection Human blood
700603 KL53 U ATCC Culture Collection Urine
Capsule and LPS antigen locus types are given where applicable, alongside the origin of the strain and indication of use as an isolation host.
LPS, lipopolysaccheride.




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































a protein column with a 30 kDa cutoff. Seven hundred fifty
microliters of concentrated phage was treated with DNase I
and Proteinase K, before phenol–chloroform, then overnight
precipitation with ammonium acetate and ethanol at -20C.
The DNA was resuspended in 50 lL of molecular-grade wa-
ter. For phage DNA with high protein contamination from the
method described earlier, the Norgen Phage DNA Isolation
Kit was used following the manufacturer’s instructions. To
assess the quantity and quality of DNA for sequencing, both a
spectrophotometer-based method and Qubit were used.
Genome sequencing
Sequencing was performed by MicrobesNG (Birming-
ham, United Kingdom); briefly, genomic DNA libraries
were prepared by using Nextera XT Library Prep Kit (Illu-
mina, San Diego) following the manufacturer’s protocol
with modifications: 2 ng of DNA were used as the input, and
a polymerase chain reaction (PCR) elongation time of 1 min.
DNA quantification and library preparations were carried
out on a Hamilton Microlab STAR automated liquid han-
dling system. Pooled libraries were quantified by using the
Kapa Biosystems Library Quantification Kit for Illumina, on
a Roche light cycler 96 quantitative PCR machine. Libraries
were sequenced on the Illumina HiSeq by using a 250 bp
paired end protocol.
Bioinformatics
Contig and genome assembly was carried out by Mi-
crobesNG; reads were trimmed with Trimmomatic 0.30,
sliding window quality cutoff of Q1528; and SPAdes (v3.7)
was used for de novo assembly.29 Genomes were annotated
by using Prokka,30 with a custom database downloaded from
Genbank as previously described.31 The capsule types of the
Klebsiella strain genomes were predicted by using Kaptive.32
To determine phage taxonomy, phage isolate genomes were
added to VIPtree33 and subject to BLASTn and tBLASTn
against NCBI. The average nucleotide identity (ANI) of our
phages was compared with the genomes identified from the
methods described earlier by using orthoANI.34 Genomes with
an ANI >95% were designated as the same species.35
For genus-level clustering, a shared protein network anal-
ysis was performed by using vConTACT2 (v0.9.13)36 with all
phage genomes available (May 2020).31 The resulting net-
work graph was visualized and annotated within Cytoscape
(v3.8.0).37 Finally, sequence alignments were performed by
using MAFFT (v7.271)38 on the DNA polymerase, large ter-
minase subunit, and major capsid proteins of each phage isolate
genus with the most closely related phage proteins. Phyloge-
netic trees were constructed with RaxML (v8.2.4)39 with 1000
bootstrap calculations by using the GAMMA model of hetero-
geneity and the maximum-likelihood method based on the JTT
substitution matrix. Subsequent trees were visualized and an-
notated in R (v3.6.1) by using ggtree (v1.16.6)40,41 and phytools
(v0.7-70).42
Depolymerases were predicted in the phage isolate’s
structural genes, through enzymatic domains or features
common to characterized depolymerase proteins. Each pre-
diction was analyzed by BLASTP (v2.10.0), Pfam HMMER
(v3.3), and HHpred (v33.1) by using the default settings.
Sequences from biochemically characterized depolymerase
proteins that target Klebsiella spp. (Supplementary Table S1)
or the putative depolymerases from our phage isolates
(Supplementary Table S2) were used for analysis. Sequences
were aligned with Muscle (v3.8.31)43 by using SeaView (v4).44
Phylogenetic tree construction was performed with MegaX45
with 500 bootstrap calculations by using the LG model. Tree
topology searches were performed by using a combination of
NNI and NJ/BioNJ. The tree was subsequently visualized and
annotated by using iTOL(v4).46
Host range testing
Spot testing was carried out; 5 lL of phage stock serial di-
lutions was plated on to bacterial lawn, in 0.4% overlay agar.
Zones of bacterial lawn clearing, indicating cell lysis, were
recorded as follows: (1) visible plaques, (2) complete bacterial
lawn clearing, (3) turbid bacterial lawn, or (4) no effect. The
presence or absence of halos; reduced turbidity of the bacterial
lawn surrounding the plaques or clearing were also recorded.
Plaque formation and morphology
Phages were plated by using the overlay agar plaque assay
method, as described earlier, on their isolation host. Plates
were incubated overnight at 37C to allow plaques to form.
Plaque morphology was noted (halos/no halo), and photo-
graphs were taken.
Transmission electron microscopy
Pure phage stocks were imaged by transmission electron
microscopy (TEM) on glow-discharged (1 min under vac-
uum) formvar/carbon-coated copper grids (Agar Scientific
Ltd, United Kingdom). Five microliters of phage stock was
applied to a grid and incubated for 1.5 min at room tem-
perature. The grid was blotted to remove excess liquid.
A drop of 2% uranyl acetate stain was applied and incubated
for 1 min, before blotting off; staining was repeated four
times; and finally the grid was air dried. Stained phage grids
were imaged on a JEOL 2100Plus TEM. The morphology of
the phage particles was visualized in ImageJ; 30 capsids and
tails for each phage isolate were measured by using the
measure function.
Lysis period
Klebsiella cultures in the exponential growth phase were
adjusted to OD600nm of 0.2, using a spectrophotometer and
phage lysates were diluted 1:4. The OD600nm was measured
every 5 min for 16 h. Growth was compared with a positive
control culture without the addition of phages. The lysis pe-
riod was calculated by measuring the time from phage ad-
dition to a drop in culture OD600nm, relative to the positive
control, indicating bacterial cell lysis.
Virulence
Two metrics the virulence index (VP) and MV50 were
calculated based on the protocol described by Storms et al.47
Briefly, bacterial cultures were grown to the exponential
phase and adjusted (see Lysis Period section) to an optical
density equivalent to 1 · 108 cfu/mL.
In a 96-well plate, phages were serially diluted from
1 · 108 to 10 pfu/mL in 100 lL volumes. A bacterial culture
was then added in equal volume (100 lL) to the phage
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dilution, resulting in multiplicity of infections (MOIs) from
1 to 10-7. The optical density of the 96-well plate was read at
600 nm at 5 min intervals for 18 h.
The area under the curve was calculated for the bacterial-
only control and at each phage MOI, from initial infection
until the exponential growth stage. The VP at each MOI was
calculated from this by following the method described47
using RStudio (version 1.1.463). VP is a quantified measure
of the virulence of a phage against a bacterial host on a scale
of 0–1 (0 = no reduction in bacterial growth to 1, instanta-
neous complete killing); the MV50 calculates the theoretical
MOI at which a phage achieves a VP of 0.5 (half the theo-
retical maximum virulence).
Data visualization
Resulting graphs were visualized in R (v3.6.1) implemented
through RStudio (v1.1.456)48 by using the ggplot2 (v3.3.2)
package,49 with a custom color-blind palette generated from
ColorBrewer.
Results
Klebsiella capsule and LPS antigen locus types
Kaptive determined that the 24 Klebsiella strains belonged
to 18 different capsule (K) and LPS antigen (O) locus types
(Table 1). Three K. pneumoniae strains were identified as
capsule type KL2; two Klebsiella sp. were each typed as
O1v1, OL104, and KL14. All other types were unique. K.
aerogenes 30053 could not be typed.
Sequence similarity to known phages
The 30 Klebsiella phages were purified by multiple rounds
of plating, and genome sequencing showed a genome size
range from 16,548 to 268,500 bp. The Klebsiella phage ge-
nomes represented nine diverse, distinct genera, as deter-
mined by VIPtree (Fig. 1) and vConTACT2 (Fig. 2). Genome
similarities between our phage isolates and known phages are
given in Table 3.
Phage isolates were grouped at genus-level into groups A–
I, referred to, respectively, by their genera or closest iden-
tifiable taxonomy level: Nonagvirus, unclassified family/
genus, Tempevirinae unclassified, Myoviridae unclassified,
Drulisvirus, Sugarlandvirus, Taipeivirus, Slopekvirus, and
Jiaodavirus. The phage isolates of groups B–D displayed
lower sequence similarities to previously identified phages,
hence they were not classified into known genera. The se-
quence data were deposited in the ENA; accession numbers
are given in Table 2.
Alignments constructed in VIPtree33 showed that the
phage groups with the highest levels of amino acid iden-
tity and gene synteny to known phages were F, G, H, and I
(Drulisvirus, Sugarlandvirus, Taipeivirus, and Jiaodavirus
genera, respectively; Supplementary Figs. S6–S9). Phage
isolates in group F, Sugarlandvirus, showed the greatest
similarity to previously described phages (Supplementary
Fig. S6). All Sugarlandvirus isolates were grouped with
previously described vB_Kpn_IME260 and Klebsiella phage
Sugarland, except vB_KaS-Veronica, which represents a
new species based on ANI. The Sugarlandvirus isolates did
exhibit variation in their tail fiber genes (Supplementary
Fig. S7; at *75 kb). In contrast, phage isolates in group A
(Nonagvirus) were more similar to each other than previously
known phages (Supplementary Fig. S2).
There was low sequence identity between our isolates and
previously sequenced phages for groups B–D (Supplemen-
tary Figs. S3–S5); as a result, the isolates in these groups have
unresolved taxonomies. Interestingly, analysis of the phage
with the smallest genome, vB_KppS-Ant of group B, re-
vealed >99% nucleotide identity to region of the K. pneu-
moniae 30104 genome (data not shown).
For further similarity analysis between our isolates and
known phages, protein phylogenetic trees were drawn for
marker genes (DNA polymerase, major capsid protein and
terminase large subunit; Supplementary Figs. S10–S18).
Conserved branching patterns, indicating close evolution-
ary history, were observed for groups A and E–I, con-
firming that they belong to known genera (Supplementary
Figs. S10 and S14–S18), whereas groups B–D (Supple-
mentary Figs. S11–S13) do not.
Given more distant relationships between the marker pro-
tein sequences, it is proposed that group C represents a novel
genus of the subfamily Tempevirinae (Supplementary Fig. S12)
and group D represents a novel genus of the Myoviridae
family (Supplementary Fig. S13), whereas the marker genes
of the phage isolate of group B has an even more distant
relationship with phages of both Siphoviridae and Myovir-
idae families (Supplementary Fig. S11). Given the inovirus
morphology observed for group B (Fig. 5, black box), clas-
sification at the family level also remains unresolved.
Host range testing
Most phages had a host range that extended past their
isolation host and was not explained by depolymerase ac-
tivity. The number of strains infected by each phage is dis-
played in Figure 3.
The infection range of the two putatively temperate phage
genera was limited to their isolation host; Nonagvirus (except
vB_KppS-Raw, which infected one additional strain) and
unclassified family/genera (B).
The lytic phage genera Myoviridae unclassified, Dru-
lisvirus and Taipeivirus cleared a bacterial lawn in three to
seven Klebsiella strains and formed plaques in one to seven
of those strains. Sugarlandvirus phages showed a clearance
of 16 and produced plaques in 10 Klebsiella strains; Tem-
pevirinae phages were highly variable, with vB_KaS-
Gatomon and vB_KaS-Ahsoka forming plaques on only
their isolation host; and vB_Kpp-Samwise formed plaques in
seven strains and cleared a further five strains.
The broadest range were lytic phages belonging to the
subfamily Tevenvirinae; Slopekvirus and Jiaodavirus, which
demonstrated clearance in 23 and 17 strains, respectively,
and produced plaques on 13 and 9 strains, respectively.
Within these genera, the host range varied between individual
phages; from Slopekvirus, phage vB_KoM-Pickle only
formed plaques on its isolation host, yet showed lawn
clearance in 22 out of 23 Klebsiella spp. (Fig. 3).
Phage annotation
Genome annotation is notoriously difficult with phages, gi-
ven the extremes of sequence variation evident in all phage
proteins,50,51 PROKKA was used and identified key phage
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genes, for example, portal proteins, capsid genes, tail proteins,
and components of the DNA replication. In addition, PhoH was
a common feature in 18 out of 30 phages sequenced, including
phages from Myoviridae unclassified, Sugarlandvirus, Taipei-
virus, and Slopekvirus, respectively. Holin and lysin pairs were
identified in groups Nonagvirus, Tempevirinae unclassified,
and Taipeivirus, whereas endolysin and Rz1 spanin complex
genes were identified in Drulisvirus and Jiaodavirus.
Most of our isolated phages encode at least one gene an-
notated as a putative ‘‘tail-fibre’’ or ‘‘tail-spike’’ protein
(Supplementary Table S2). Structural predictions suggested
that these proteins adopt beta-helical structures, a common
protein architecture of tail-spike proteins and capsule depo-
lymerase enzymes, which are suggested to have evolved
from these purely structural proteins,52–54 These proteins
also contained predicted enzymatic domains, for example,
Pectate_lyase_3 domain or Peptidase_S74 domain, which have
been identified in other phage-encoded depolymerases.55–58
Several of the phage groups: B, C, F, H, and I, did not contain a
predicted tail-fiber depolymerase protein.
For phages encoding a candidate depolymerase, protein se-
quence relationships were mapped on a tree (Fig. 4). Phages of
the genera Nonagvirus, and Drulisvirus encode a similar pre-
dicted depolymerase protein. The putative depolymerases from
Drulisvirus phages share high sequence conservation (*95%
identity, 100% query) to the experimentally characterized de-
polymerase Kpv74_56 from the closely related Drulisvirus,
K. pneumoniae phage KpV74,59 and all these characterized
phages infect K2 capsule-producing strains of Klebsiella;
however, the Nonagvirus isolates in our study do not (Fig. 4).
FIG. 1. Protein-level phylogenetic tree, generated by VIPtree. Klebsiella phage isolates (+). A–I denote phage groups
with the following genera: A (red) Nonagvirus; B (black) unclassified family/genus; C (blue) Tempevirinae unclassified; D
(lime) Myoviridae unclassified; E (green) Drulisvirus; F (purple) Sugarlandvirus; G (orange) Taipeivirus; H (brown)
Slopekvirus; and I (pink) Jiaodavirus. Icons indicate phage morphology.
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Interestingly, the phages of two further genera; Myoviridae
unclassified (vB_KqM-Eowyn) and Taipeivirus (vB_KqvM-
LilBean, vB_KqvM-Bilbo and vB_KqvM-Westerburg) con-
tain multiple putative depolymerase proteins (7, 4, 4, 5,
respectively; Fig. 4). The putative depolymerase-like pro-
teins of vB_KqM-Eowyn (Myoviridae unclassified) show
low identity to previously characterized depolymerases
(Fig. 4). From our host range assays, these phages showed
activity toward strains that produced a small subset of
K-antigens (vB_KqM-Eowyn—KL16, KL110; vB_KqvM-
LilBean—KL35; vB_KqvM-Bilbo—KL35, K2 and vB_KqvM-
Westerburg—KL35, KL2, KL3).
Morphology of phages
Phage-induced plaques in the lawns of host bacteria varied
in size, and in the presence/absence of halos surrounding the
phage plaques. Representative images of phage plaques for
each described genera are presented in Figure 5. A diffuse
halo around the phage plaques was observed in 15 of the 30
phage isolates (Supplementary Table S3 and Fig. 5).
Representative TEM images of the described phage gen-
era are provided in Figure 5. Average tail length and cap-
sid widths are given in Supplementary Table S3 (based on
30 particles per phage), and a representative TEM image
for each phage is given in Figure 5. Of the phages imaged, 13
are myovirus, 13 are siphovirus, 3 are podovirus, and 1 is
inovirus.
The largest phage in this study was vB_KvM-Eowyn
(Myoviridae unclassified), which had a capsid width of
140 nm and a tail length of 140 nm; this corresponded to the
largest genome at 269 kbp. The smallest caudovirale phage
was vB_KqP-Goliath, a podovirus (Drulisvirus), with a capsid
width of 41 nm and tail length of 10 nm, had the second
smallest genome at 44 kbp, after the filamentous prophage
vB_KppS-Ant (unclassified family/genus). vB_KppS-Raw
(Nonagvirus), a siphovirus, had a comparable capsid size of
46 nm, but a substantially longer tail (153 nm) and genome of
61 kbp. The smallest caudovirale phages (Drulisvirus) pro-
duced the largest plaques and halos, hence the name KqP-
Goliath (Supplementary Table S1 and Fig. 5).
Phage lysis period and virulence in host strains
The lysis period and virulence indices (VP and MV50) of
each phage, in their relevant isolation host strain in LB at 37C,
are displayed in Figure 6. For six phages a lysis period was not
achieved (vB_KppS-Eggy, vB_KppS-Pokey, vB_KppS-Ant,
vB_KpM-Milk, vB_KpM-KalD, and vB_KpM-SoFaint), and
the growth curve of the bacteria was dampened (except
vB_KppS-Ant); however, the culture density did not crash
compared with the positive control—indicative of temperate
phages. These phages also demonstrated a below-average VP,
close to 0 (with the exception of vB_KpM-KalD), indicating
little difference in growth curves between the control and
phage-infected cultures (Fig. 6).
Of the phages with a lysis period, the median time was
*70 min, ranging from 15 to 210 min. There was no corre-
lation between lysis period and the virulence measures
(Fig. 6; statistical data not shown). The average VP was 0.33
(range 0.06–0.64) and MV50 was achieved with a projected
MOI of 4.17 · 1017 (range 3.5 · 10-7 to 1 · 1019) for the lytic
phage genera. The putatively temperate phages had lower
virulence measures; average VP 0.06 (range -0.07 to 0.36)
and MV50 returned a theoretical MOI of 6.00 · 1058 (range
0.012 to 3 · 1059).
FIG. 2. Network analysis of phage-encoded proteins calculated with vConTACT2. Colored, numbered nodes represent
our Klebsiella phage isolates, colored according to the phage group and subsequent genera to which each phage belongs.
Numbers within nodes indicate the lab identification numbers (Table 2). Our Klebsiella phage isolates are colored according
to the genera to which the phage belongs: red, Nonagvirus; gray, unclassified; blue, Tempevirinae unclassified; lime,
Myoviridae unclassified; green, Drulisvirus; purple, Sugarlandvirus; orange, Taipeivirus; brown, Slopekvirus; and Pink,
Jiaodavirus. The numbers are the lab identification numbers (Table 2). Smaller, black nodes represent previously sequenced
phages as references. Edges between nodes represent shared proteins, such that many connecting edges imply greater
pairwise shared protein content. Phage nodes are clustered based on shared proteins, with a spring-embedded (force
directed) layout visualization created in Cytoscape.





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Tempevirinae unclassified, Drulisvirus, Sugarlandvirus,
and Jiaodavirus had the highest virulence (VP) (range 0.12–
0.64, average 0.42) and below-average MV50 (range
3.5 · 10-7 to 1.30 · 105, average 9.30 · 103), indicating that
they rapidly killed their hosts and needed a lower phage:host
ratio to achieve this. It is, however, difficult to generalize for
each genus, because the metrics varied drastically within
genera. The virulence index results are specific to each phage
and conditions assessed, and therefore they are not directly
comparable between phages grown on different hosts.
Discussion
Klebsiella-infecting phages, belonging to nine phyloge-
netically distinct lineages, were isolated from water samples
sourced from different environments. The 30 phages were
discovered by using a panel of K. pneumoniae, K. oxytoca, K.
quasipneumoniae, K. aerogenes, and K. variicola. These
Klebsiella spp. represent clinical and environmental strains
that span 18 different capsule types.
This study discovered several phages and phage genera that
have not previously been described. Phylogenetic analysis
revealed that the filamentous phage vB_KppS-Ant did not
significantly cluster with any known phages at the shared
protein level, and therefore represents a novel genus. The ge-
nome reconstruction of this ssDNA phage is unexpected,
however previously studies have demonstrated Illumina se-
quencing to be inefficient yet successful at sequencing ssDNA
phages.60 The high sequence similarity of phage vB_KppS-
Ant to a region of the K. pneumoniae 30104 genome (>99%)
indicates that it is an induced prophage. By combining shared
protein network analysis and marker gene phylogenetic tree
analysis, we identified two further novel phage genera: Tem-
pevirinae unclassified and Myoviridae unclassified.
Factors determining host range
In general, comparative genomics revealed sequence
conservation over a large portion of their genomes, with
variability in only a few genes (Supplementary Figs. S4–
FIG. 3. Phage host range matrix. Host range was determined by spot testing on LB agar overlay plates against the
Klebsiella spp. in our panel. The Klebsiella capsule and LPS antigen locus have been designated by Kaptive. The phage
names labels are colored according to the phage group and subsequent genera to which each phage belongs: A (red)
Nonagvirus; B (black) unclassified family/genus; C (blue) Tempevirinae unclassified; D (lime) Myoviridae unclassified; E
(green) Drulisvirus; F (purple) Sugarlandvirus; G (orange) Taipeivirus; H (brown) Slopekvirus; and I (pink) Jiaodavirus.
The number of putative depolymerases identified by BLAST/HMMER analysis is given under the phage name. In the
matrix, dark blue indicates the host of isolation, in which plaques were produced; light blue indicates the non-host strains
where plaques were produced in a bacterial lawn; red indicates that spot testing caused the bacterial lawn to clear, but no
plaques were visible; dark red indicates that some reduction in the turbidity of the bacterial lawn was observed, but no
plaques; gray indicates no observed effect; and yellow triangle overlays indicate that a halo of reduced turbidity of the
bacterial lawn was observed surrounding the plaques or clearing. LB, lysogeny broth; LPS, lipopolysaccheride.






























































































































































































































































































































































































































































































































































































































































































































































S11), resulting in divergent characteristics in terms of host
range and virulence (Figs. 3 and 6). Despite several of these
phage species having been identified in previous studies,
there are examples where these showed differences in host
range. Thus, even within the small sample presented here,
there is information to be gained about the factors deter-
mining host range.
It has been suggested that selection pressure imposed from
the use of a host is sufficient to amplify nongenetic variants of
a phage that can cross host -range,47,61 and it also remains
possible that uncharacterized genes, encoding proteins of
unknown function, could adapt a given phage to a distinct
host.62 By way of example, Sugarlandvirus phages showed a
high degree of similarity between genome sequences, with
most variation concentrated in their tail fiber genes. Tail fi-
bers mediate interaction with host cell receptors and are
frequently rearranged in phages, allowing them to adhere to
bacterial hosts.63 These tail fibers can include domains with
enzymatic function, enabling degradation of host-specific
features such as polysaccharide capsules.64
Three phages with >99% genome sequence similarity were
isolated on two distinct hosts: K. pneumoniae 30104 (vB_
FIG. 6. Lysis period and virulence indices are not correlated, but temperate phages are less virulent. (A) Displays the
virulence index of the phages. Virulence index is a quantified measure of the phage, in their respective isolation host
(Table 2), in LB with 5 mM each of CaCl2 and MgCl2, at 37C. (B) displays the MV50, the MOI at which each phage
achieves 50% of their maximal theoretical virulence. Both of these virulence measures are described in more detail by
Storms.47 (C) Displays the lysis period of the phage. Where this is left blank, a lysis period could not be established, usually
indicating temperate lifestyle. Individual points are colored based on phage group and the subsequent genera to which each
phage belongs: A (red) Nonagvirus; C (blue) Tempevirinae unclassified; D (lime) Myoviridae unclassified; E (green)
Drulisvirus; F (purple) Sugarlandvirus; G (orange) Taipeivirus; H (brown) Slopekvirus; and I (pink) Jiaodavirus. Dashed
lines indicate the median values for each metric. MOI, multiplicity of infection.
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KppS_Ponyo and vB_KppS_Totoro) or K. aerogenes 30053
(vB_KaS-Benoit). vB_KppS_Ponyo and vB_KaS-Benoit
are 100% identical at the nucleotide level, and vB_KppS_
Totoro has a single nucleotide polymorphism (SNP).
Host range analysis showed that the two phages propa-
gated on K. pneumoniae 30104 had comparable host ranges,
whereas the phage propagated on K. aerogenes 30053 had a
slightly different host range (Fig. 3). This indicates that the
propagation host, influenced host range, and that genome
sequence alone cannot be used to infer host range.65 This is
a vitally important consideration for phage therapy, and we
cannot generalize phage behavior based on genome similarity,
but we must also consider prevailing culture conditions.66
Although multiple features of strain-specific bacterial
immunity can protect against phage replication, in Klebsiella
the primary defense against both phages and antibiotics is a
protective polysaccharide capsule.67,68 This capsule forms
the outermost layer of the Klebsiella cell and acts as an
important virulence factor.69 There are at least 77 different
serologically defined Klebsiella capsule types.70,71 Whole-
genome capsule typing32 showed that our Klebsiella panel
encompassed 18 capsule types, including three KL2 strains,
which are important in clinical infections and therefore of
interest to develop effective therapies.9
Klebsiella phages have repeatedly shown to be specific to
host capsule types,72–74 and this is often linked to phage sugar-
degrading enzymes called depolymerases that target specific
capsule types.56,59,75 Given the broad host ranges observed in
our collection of phages (Fig. 3) and depolymerase-indicative
halos76 in 83% of our phage isolates (Supplementary Table S3),
we sought to identify depolymerase genes.
A surprisingly high number of putative depolymerase genes
(7) were identified in vB_KvM-Eowyn (Myoviridae unclas-
sified), which only produced plaques in its KL16 host strain,
but showed potential depolymerase activity against a KL110-
producing strain.
The Taipeivirus phages encoded four to six depolymerases,
each of which also exceeded the number expected53; these
phages produced plaques against the clinically relevant KL2
capsule type. These depolymerases have yet to be verified, and
a wider panel of Klebsiella capsule types is necessary to
confirm their activity. Klebsiella phages encoding up to 11
depolymerase genes have previously been characterized, but
these infect a correspondingly wide range of Klebsiella cap-
sule types,77 indicating a need to expand our Klebsiella panel.
Nonagvirus and Drulisvirus phages encoded one depoly-
merase gene each and demonstrated a small host range
(Fig. 3). Characterization of these putative depolymerase
genes will be important to further investigate the potential
host range of these phages, beyond our current analysis.
Genes encoding depolymerases were not identifiable in all of
our halo-producing phages, including in some of the
broadest ranging phages: Sugarlandvirus, Slopekvirus, and
Jiaodavirus. The phage with the broadest host range, KoM-
MeTiny (Slopekvirus), showed lawn clearance in 79% and
produced plaques in 42% of the Klebsiella tested, which
included nine different capsule types, but had no identifiable
depolymerase genes. We suggest that this is either because
they lack depolymerases or due to inadequate tools for de-
polymerase identification.50,51
There is limited sequence conservation between many of
the putative tail-fiber/tail-spike depolymerase proteins from
our phages and biochemically validated depolymerases,
therefore further characterization will be critical to optimize
phage cocktails for therapeutic use.
Application to future phage-based therapy
None of our lytic phages was able to suppress Klebsiella
growth for more than 12 h (Supplementary Fig. S1). In addi-
tion, selecting effective phages for the bacteria to be targeted
can improve phage performance; phage vB_KoM_Liquor
had an exceptionally long lysis period of 210 min, possibly
due to poor propagation in the isolation host K. oxytoca
170821. Phage cocktails are used to improve the impact of
phages on Klebsiella populations and are considered crucial
for the efficacy of phage therapy.78–80 Phage cocktails
benefit from complementarity and redundancy between the
phages to overcome host-evolved phage resistance,81 which
may account for the resurgences seen in our Klebsiella cultures.
After phage selection, the testing of phage combinations is
essential to avoid adverse effects, which could result in
bacterial stress responses or biofilm formation, as seen with
sub-lethal antibiotic use.82,83 The phages described in this
study have been supplied for use in compassionate phage
therapy cocktails, requiring rigorous and lengthy testing to
ensure safety and activity against the clinical Klebsiella.
For use in phage therapy, phages must not encode toxins or
AMR genes.78,80,84 Fortunately, none of our Klebsiella pha-
ges contained either. Other factors, for example, the host
infection dynamics and low virulence of the Nonagvirus in-
dicate that these isolates may be temperate and/or may not be
curative on infections. The temperate phage vB_KppS-Ant,
as the only phage with an identifiable integrase for lysogeny,
will be excluded for phage therapy purposes.85 Jiaodavirus
phages encode a Hoc-like protein, which in phage T4 has
been demonstrated to be highly immunogenic.86 It should be
established as to whether these phages cause an immune re-
sponse before using them for phage therapy.
The genomic information and experimental data presented
here for Tempevirinae unclassified, Sugarlandvirus, Taipei-
virus, and Slopekvirus indicate that they are lytic and, thus,
suitable for preclinical evaluation. We suggest that the Su-
garlandvirus and Slopekvirus isolates are the best candidates
for future development in phage therapy, given their broad
host range, high virulence, short latency period, and lack of
potentially harmful genes. Taken together, our data suggest
that to provide universal, effective phage therapy against
Klebsiella infections, a phage cocktail comprising multiple
diverse phages should be developed.
Conclusions
A diverse range of Klebsiella phages were isolated. De-
spite some of our phage isolates being grouped into a single
previously described phage species, within-species variation
in both host range and virulence was observed. This dem-
onstrates the necessity to microbiologically characterize
phages for therapeutic use.
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